Cargando…

Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b

BACKGROUND AND PURPOSE: Japanese encephalitis (JE) is caused by the JE virus of the Flaviviridae family and is spread by mosquito bites, and no specific antiviral treatment for it exists. Here we describe the clinical presentations, laboratory findings, clinical outcomes, and adverse events after co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Son, Hyoshin, Sunwoo, Jun-Sang, Lee, Sang Kun, Chu, Kon, Lee, Soon-Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242325/ https://www.ncbi.nlm.nih.gov/pubmed/34184451 http://dx.doi.org/10.3988/jcn.2021.17.3.428

Ejemplares similares

Reemergence of Japanese Encephalitis in South Korea, 2010–2015
por: Sunwoo, Jun-Sang, et al.
Publicado: (2016)

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Paraneoplastic encephalitis associated with renal cell carcinoma
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Telemedicine in epilepsy and encephalitis: previous research and indication guidelines in Korea
por: Jang, Yoonhyuk, et al.
Publicado: (2022)

Autoimmune limbic encephalitis combined with leptomeningeal metastases of non-small cell lung cancer: treatment response to osimertinib, immunoglobulin, rituximab, and tocilizumab
por: Lee, Seolah, et al.
Publicado: (2023)

Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
por: Lim, Jae Hee, et al.
Publicado: (2011)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017)

Refractory neuro-Sweet disease successfully treated with tocilizumab and mycophenolate mofetil
por: Hwang, Sungeun, et al.
Publicado: (2021)

Treatment strategies for autoimmune encephalitis
por: Shin, Yong-Won, et al.
Publicado: (2017)

Cutaneous side effects of combination therapy of pegylated interferon 2α and ribavirin
por: Raducan, Anca, et al.
Publicado: (2014)

The Laboratory Diagnosis of Autoimmune Encephalitis
por: Lee, Sang Kun, et al.
Publicado: (2016)

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
por: Falzarano, Darryl, et al.
Publicado: (2013)

Pentoxifylline inhibits replication of Japanese encephalitis virus: a comparative study with ribavirin
por: Sebastian, Liba, et al.
Publicado: (2009)

Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea
por: Kim, Hyeong Il, et al.
Publicado: (2012)

Five-Year Retention of Perampanel and Polytherapy Patterns: 328 Patients From a Single Center in South Korea
por: Park, Kyung-Il, et al.
Publicado: (2023)

Lesion Detection Through MRI Postprocessing in Pathology-Proven Focal Cortical Dysplasia: Experience at a Single Institution in the Republic of Korea
por: Son, Hyoshin, et al.
Publicado: (2023)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Anti-N-methyl-D-aspartate receptor encephalitis 8 years after serial herpes simplex virus type 1 and human herpesvirus type 7 encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010)

Mx Is Not Responsible for the Antiviral Activity of Interferon-α against Japanese Encephalitis Virus
por: Zhou, Jing, et al.
Publicado: (2017)

Proportion of peripheral regulatory T cells in patients with autoimmune encephalitis
por: Byun, Jung-Ick, et al.
Publicado: (2021)

Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014)

High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
por: Jung, Hee Jae, et al.
Publicado: (2014)

Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro
por: Anderson, John F., et al.
Publicado: (2002)

Efficacy and Long-Term Follow Up of Combination Therapy with Interferon Alpha and Ribavirin for Chronic Hepatitis C in Korea
por: Kim, Jie-Hyun, et al.
Publicado: (2006)

Clearance of HCV by Combination Therapy of Pegylated Interferon α-2a and Ribavirin Improves Insulin Resistance
por: Kim, Hong Joo, et al.
Publicado: (2009)

Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro
por: Teng, Lichen, et al.
Publicado: (2014)

Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope?
por: Vogel, Wolfgang
Publicado: (2004)

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
por: You, Byung Chul, et al.
Publicado: (2012)

Postvaccinal GABA‐B receptor antibody encephalitis after ChAdOx1 nCoV‐19 vaccination
por: Ahn, Seon‐Jae, et al.
Publicado: (2022)

Prognostic Value of Initial Standard EEG and MRI in Patients with Herpes Simplex Encephalitis
por: Kim, Young-Soo, et al.
Publicado: (2016)

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
por: Aizawa, Nobuhiro, et al.
Publicado: (2013)

Adult‐onset rapidly worsening progressive myoclonic epilepsy caused by a novel variant in DHDDS
por: Kim, Seondeuk, et al.
Publicado: (2021)

The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
por: Tran, Huy A, et al.
Publicado: (2005)

Adverse Skin Reactions due to Ribavirin in Hepatitis C Combination Therapy with Pegylated Interferon-α(2a)
por: Shindo, Masahisa, et al.
Publicado: (2013)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_se8laul0raoqc71tqts3egaqe9